Since Allecra Therapeutics was founded in 2013, it has participated in 2 rounds of funding. In total Allecra Therapeutics has raised $44.4M. Allecra Therapeutics' last funding round was on Jun 2016 for a total of $24.7M.
Allecra Therapeutics has 4 investors, including Delos Capital, Forbion Capital Partners and Edmond de Rothschild Investment Partners. The latest investment occurred in Jun 2016.